ストックスクリーナーアプリを入手
0.80
4.14%
0.0318
Psyence Biomedical Ltd (PBM) 最新ニュース
How Psyence Biomedical Ltd. stock performs in weak economyJuly 2025 Selloffs & Risk Adjusted Buy and Sell Alerts - ulpravda.ru
What is the fair value of Psyence Biomedical Ltd. stock nowFit and Size Notes & lightweight options for faster days - ulpravda.ru
Comparing Compugen (NASDAQ:CGEN) & Psyence Biomedical (NASDAQ:PBM) - Defense World
Is Psyence Biomedical Ltd. stock attractive for hedge fundsWeekly Trade Report & Expert Curated Trade Setup Alerts - ulpravda.ru
Surprises Report: Will Psyence Biomedical Ltd. Equity Warrant stock gain from strong economyJuly 2025 Breakouts & Daily Price Action Insights - ulpravda.ru
Will Psyence Biomedical Ltd. stock benefit from infrastructure spendingJuly 2025 PostEarnings & Reliable Breakout Forecasts - ulpravda.ru
Why Psyence Biomedical Ltd. stock could benefit from AI revolutionWeekly Stock Summary & Daily Growth Stock Tips - ulpravda.ru
What valuation multiples suggest for Psyence Biomedical Ltd. Equity Warrant stockQuarterly Investment Review & Reliable Intraday Trade Alerts - ulpravda.ru
Psyence Biomedical Calls January 22, 2026 Shareholder Meeting to Vote on Financials, Board and Share Consolidation - TipRanks
How currency fluctuations impact Psyence Biomedical Ltd. Equity Warrant stock2025 Trading Volume Trends & Low Volatility Stock Recommendations - ulpravda.ru
Can Psyence Biomedical Ltd. stock rebound after recent weaknessWeekly Trade Report & Reliable Intraday Trade Alerts - ulpravda.ru
Will Psyence Biomedical Ltd. Equity Warrant stock deliver consistent dividendsMarket Activity Recap & Weekly Breakout Watchlists - ulpravda.ru
Why Psyence Biomedical Ltd. Equity Warrant stock appeals to analystsWeekly Stock Analysis & Expert Verified Stock Movement Alerts - ulpravda.ru
How Psyence Biomedical Ltd. stock reacts to oil pricesWeekly Earnings Recap & Technical Confirmation Trade Alerts - ulpravda.ru
Psyence Biomedical Ltd.Ordinary Shares (NQ: PBM - FinancialContent
Psyence Biomedical announces milestone in natural ibogaine HCl production - TipRanks
Psyence Biomedical Ltd. Announces Board Changes - MarketScreener
Psyence BioMed Achieves Milestone in Natural Ibogaine HCl Production and Strengthens Balance Sheet With No Debt and $12m Cash - The Manila Times
Psyence BioMed Achieves Milestone in Natural Ibogaine HCl - GlobeNewswire
Published on: 2026-01-04 19:06:08 - Early Times
Investment Recap: Why Psyence Biomedical Ltd Equity Warrant stock appeals to analystsCPI Data & Real-Time Market Sentiment Alerts - moha.gov.vn
Gainers Report: Why Psyence Biomedical Ltd stock could benefit from AI revolutionSell Signal & Real-Time Chart Pattern Alerts - moha.gov.vn
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing - TMX Newsfile
Psyence Biomedical (NASDAQ:PBM) Trading Down 6.1% – Here’s Why - Defense World
Published on: 2025-12-20 18:04:24 - Улправда
Will Psyence Biomedical Ltd. stock benefit from upcoming earnings reportsJuly 2025 Decliners & Technical Buy Zone Confirmations - Улправда
Investment Review: Is Psyence Biomedical Ltd. stock attractive for hedge fundsDay Trade & Safe Capital Growth Plans - moha.gov.vn
Psyence Biomedical’s psilocybin approved for Phase IIb trial use By Investing.com - Investing.com Nigeria
{Company Name} Stock Soars on Exciting Developments - StocksToTrade
Psyence Biomedical stock rises after ethics approval for psilocybin trial By Investing.com - Investing.com South Africa
Psyence Biomedical stock rises after ethics approval for psilocybin trial - Investing.com India
Psyence Biomedical Ltd. Announces Approval for Use of Psylabs' Psilocybin Product in Phase IIb Clinical Trial - MarketScreener
Psyence BioMed Announces Approval for Use of PsyLabs’ Psilocybin Product in Phase IIb Clinical Trial - The Manila Times
Psyence BioMed announces approval for use of Psylabs' psilocybin product in phase IIb clinical trial - marketscreener.com
Psyence Biomedical’s psilocybin approved for Phase IIb trial use - Investing.com
Psyence BioMed Announces Approval For Use Of Psylabs’ Psilocybin Product In Phase IIb Clinical Trial - TradingView — Track All Markets
Will Psyence Biomedical Ltd. Equity Warrant stock gain from government policies2025 Institutional Moves & Stock Timing and Entry Methods - Улправда
New Highs: Will Psyence Biomedical Ltd. stock benefit from upcoming earnings reportsForecast Cut & Real-Time Sentiment Analysis - Улправда
Will Psyence Biomedical Ltd. stock beat EPS estimatesPortfolio Performance Report & Low Risk Entry Point Tips - ulpravda.ru
Why Psyence Biomedical Ltd. Equity Warrant stock is popular among millennialsWeekly Gains Report & Fast Gaining Stock Strategy Reports - Улправда
Is Psyence Biomedical Ltd. Equity Warrant stock dividend yield sustainableJuly 2025 Selloffs & Weekly Consistent Profit Watchlists - Улправда
Why Psyence Biomedical Ltd. Equity Warrant stock remains a top recommendation2025 Bull vs Bear & Low Risk High Reward Trade Ideas - Улправда
How geopolitical tensions affect Psyence Biomedical Ltd. stock2025 Trading Recap & AI Powered Trade Plan Recommendations - Улправда
Psyence Biomedical Ltd. (PBM) -5.7% in After-hours: Despite No Clear Catalyst - Stocks Telegraph
Psyence BioMed Advances Phase IIb Clinical Trial and Expands Board - MSN
Check out these key findings about Psyence Biomedical Ltd (PBM) - setenews.com
Rapid Surge: Psyence Biomedical’s Unexpected Stock Movement - StocksToTrade
Psyence BioMed (PBM) Stock: Drives Forward with Phase IIb Trial and Unique Longevity Science Position - parameter.io
Psyence Biomedical Ltd. (PBM) Stock: Drops, But Company Pushes Forward with Groundbreaking Psychedelic Therapies - parameter.io
Psyence BioMed CEO Letter Highlights Clinical Progress, Ethical sourcing of Ibogaine, Strong Cash Position and Expanding Leadership in Longevity Science - Asianet Newsable
Psyence BioMed CEO Letter Highlights Clinical Progress, Ethical Sourcing of Ibogaine, Strong Cash Position and Expanding Leadership in Longevity Science - The Manila Times
Bull Run: Why Psyence Biomedical Ltd stock appeals to dividend seekersTrade Performance Summary & Long-Term Growth Portfolio Plans - moha.gov.vn
How Psyence Biomedical Ltd. Equity Warrant stock benefits from global expansionJuly 2025 Market Mood & Reliable Entry Point Alerts - Newser
Will Psyence Biomedical Ltd. Equity Warrant stock remain a Wall Street favoriteWeekly Gains Report & Reliable Volume Spike Trade Alerts - Newser
Will Psyence Biomedical Ltd. Equity Warrant stock sustain high P E ratiosAnalyst Downgrade & Safe Entry Trade Signal Reports - Newser
0.90%
大文字化:
|
ボリューム (24 時間):